Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 47

Results For "foundation"

755 News Found

NHA organizes a multi-stakeholder meet for ABDM microsites
News | December 20, 2023

NHA organizes a multi-stakeholder meet for ABDM microsites

ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring


KBR and HJF bags contract to aid military neuroscience research
News | December 20, 2023

KBR and HJF bags contract to aid military neuroscience research

KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE


Moderna Chief Commercial Officer steps down, President to look over pipeline strategy
People | December 14, 2023

Moderna Chief Commercial Officer steps down, President to look over pipeline strategy

Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025


Evonik launches Ecohance Soft Baobab oil for natural cosmetic formulations
Sustainability | December 04, 2023

Evonik launches Ecohance Soft Baobab oil for natural cosmetic formulations

High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative


Bayer commits to Veeva Vault CRM and Veeva OpenData globally
News | November 29, 2023

Bayer commits to Veeva Vault CRM and Veeva OpenData globally

Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data


Bayer and Recursion focus research collaboration on Oncology
Digitisation | November 14, 2023

Bayer and Recursion focus research collaboration on Oncology

Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients


Sumitomo Pharma announces authorization in Canada of Orgovyx for treatment prostate cancer
News | October 25, 2023

Sumitomo Pharma announces authorization in Canada of Orgovyx for treatment prostate cancer

Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada


ERS Genomics completes licensing agreement with Syngene International
News | October 23, 2023

ERS Genomics completes licensing agreement with Syngene International

Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners


India should take global leadership with Holistic Healthcare Approach: Sonowal
Policy | October 23, 2023

India should take global leadership with Holistic Healthcare Approach: Sonowal

New Molecular biology lab launched, AIIA increased its work scope in form of MoUs


Daiichi Sankyo, Merck collaborate to develop and commercialize three Daiichi Sankyo DXd ADCs
News | October 20, 2023

Daiichi Sankyo, Merck collaborate to develop and commercialize three Daiichi Sankyo DXd ADCs

Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months